Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Labroots Announces Full Three-Day Agenda for its 10th Annual Cancer Research & Immuno-Oncology Week Event, Held on October 4-6, 2022
  • USA - English


News provided by

Labroots

Sep 21, 2022, 15:30 ET

Share this article

Share toX

Share this article

Share toX

Cancer Research & Immuno-Oncology Week - October 4-6, 2022
Cancer Research & Immuno-Oncology Week - October 4-6, 2022

This free event brings together thousands of innovative researchers, leading industry and academia experts, scientists, clinicians, oncologists and healthcare to learn the latest breakthroughs in the promising fields of cancer research and immuno-oncology

YORBA LINDA, Calif., Sept. 21, 2022 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website offering premier, interactive virtual events and webinars, is hosting its 10th annual Cancer Research and Immuno-Oncology Week conference on October 4-6, 2022. The three-day content-rich agenda continues to be the go-to-meeting sharing cutting-edge discoveries and novel advancements via invited lectures and thought-provoking discussions to improve the outcomes and treatments of patients with cancer.

Cancer Research & Immuno-Oncology Week offers a prestigious forum for some of the brightest minds in the field to collaborate and share knowledge in emerging topics including cancer research, novel targeted therapies in cancer, immuno-oncology, cell therapy, and cancer research networks, epidemiology and patient advocacy.

Over 30 educational and sponsored presentations will be presented by distinguished speakers covering all aspects of cancer care and immunotherapies with sessions on cancer health disparities – using genomics to influence clinical applications, single-cell methods for cancer discovery, using image analysis in cancer research and treatment, cancer systems biology, using spatial transcriptomics to dissect the tumor microenvironment, innovative approaches to target the oncoprotein K-Ras in cancer, neoantigen vaccines, next-generation checkpoint targets, overcoming the inhibitory tumor microenvironment, emerging cell therapies (beyond CAR T cells), and much more.

Naming just a few highlights, kicking off day one, Laura Yerly, PhD Candidate, Lausanne University Hospital CHUV, Laboratory of François Kuonen, MD, PD-MER, PhD will explore the invasive niche of basal cell carcinoma as revealed by integrated multi-omics with live Q&A during this presentation sponsored by NanoString Technologies.

Shortly thereafter, attendees will hear from keynote speaker Dr. Hugo Aerts, Director, Artificial Intelligence in Medicine (AIM) Program, Associate Professor, Harvard University, sharing a presentation titled, "Artificial Intelligence for Medical Imaging" with live Q&A. "While recent advances in AI have led to a profusion of studies that apply deep learning to problems in medicine, many of these algorithms fail to bridge the gap from a research study towards clinical application," said Hugo Aerts, founding Director of the Artificial Intelligence in Medicine (AIM) program, Mass General Brigham and Harvard Medical School. "At this conference, I will discuss our approach to bridge this translational gap towards the clinic and will conclude with a discussion on the need for open-source deep learning frameworks that are transparent and reproducible."

The second keynote presentation on day three also with live Q&A is presented by Chadi Nabhan, MD, MBA, FACP, Chairman, Precision Oncology Alliance & Adjunct Professor, University of South Carolina, Department of Clinical Pharmacy & Outcomes Sciences, Caris Life Sciences to explore precision oncology alliance: a vision to the future, you won't want to miss! "The Caris Precision Oncology Alliance (POA0) is the premiere precision oncology consortium in the world focusing on advancing research to improve the outcomes of patients with cancer. Through the diverse contributions of our 71 members, we work towards investigating and understanding the latest scientific developments in genomics to advance the integration of molecular profiling into all aspects of cancer care through innovation and research. We look forward to sharing how this network was incepted, and how it contributes to the future of precision medicine at the upcoming Labroots conference," commented Dr. Chadi Nabhan, Chairman, Prescision Oncology alliance & Adjunct Professor, University of South Carolina, Department of Clinical Pharmacy and Outcome Sciences.

"We're thrilled to produce this must-attend event for 10 consecutive years, promising to expand your knowledge in the fast-developing interdisciplinary fields of cancer research and immuno-oncology," said Greg Cruikshank, Chief Executive Officer of Labroots. "We're proud to be on the forefront of driving emerging research on immunotherapies in combination with other anti-cancer targeted therapies via Labroots' unique educational platform, with the aim to significantly improve the lives of patients and to fight cancer."

Produced on Labroots' signature platform, this online environment allows participants to connect across desktop and mobile devices delivering a seamless educational experience. The interactive environment features a lobby equipped with leaderboard and gamification, an auditorium, featuring live-streaming video webcasts offering live attendee chats during scheduled presentations, a poster hall with a poster competition, and attendees can explore data and engage in live chat conversations, an exhibit hall to interact with sponsors and view their recent contributions in the field, and lastly a networking lounge to connect and collaborate with colleagues. By participating in this event, you can earn 1 Continuing Education credit per watched presentation for a maximum of 35 credits.

To register for the event, click here. Use the hashtag #LRcancer to follow the conversation and connect with members of the global Cancer & Oncology Research community! Follow @Cancer_LR on Twitter and @CancerResearchandOncology.LR on Facebook to connect with our specialist Cancer & Oncology writers and stay up to date with the latest news in Cancer & Oncology Research. Now, you can also join our Cancer Research & Oncology networking group on LinkedIn!

About Labroots
Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events. Now, Labroots offers more than ever with Chati, a flexible, highly scalable event platform that allows for the creation of unique, effective, and memorable virtual events.

Media Contact

Lynn Brainard, Labroots, 714-771-4397, [email protected]

Twitter

SOURCE Labroots

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.